The prognostic implications of EGFR mutation and ALK rearrangement for the long-term outcomes of patients with resected lung adenocarcinomas.
Hyungjin KimHyun Ju LeeHyunsook HongYoung Jae KimKwang Gi KimYoon Kyung JeonYoung Tae KimPublished in: Thoracic cancer (2019)
EGFR mutation was independently prognostic of the long-term outcomes of patients with surgically treated lung adenocarcinomas. A more favorable prognostic effect was seen in younger than in older patients. ALK rearrangement was not associated with OS.